ArticleFrontiers in immunology2024

Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer.

Chen Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.